Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$0.35 - $3.28 $119,524 - $1.12 Million
-341,500 Reduced 44.44%
426,908 $149,000
Q1 2023

May 15, 2023

SELL
$3.28 - $4.81 $614,016 - $900,431
-187,200 Reduced 19.59%
768,408 $2.66 Million
Q4 2022

Feb 14, 2023

SELL
$3.65 - $4.82 $999,735 - $1.32 Million
-273,900 Reduced 22.28%
955,608 $4.28 Million
Q3 2022

Nov 14, 2022

SELL
$2.66 - $3.97 $2.05 Million - $3.06 Million
-770,900 Reduced 38.54%
1,229,508 $4.48 Million
Q2 2022

Aug 15, 2022

BUY
$2.42 - $4.05 $188,276 - $315,090
77,800 Added 4.05%
2,000,408 $5.3 Million
Q1 2022

May 16, 2022

BUY
$3.45 - $5.83 $685,515 - $1.16 Million
198,700 Added 11.53%
1,922,608 $7.54 Million
Q4 2021

Feb 14, 2022

BUY
$4.89 - $7.59 $2.02 Million - $3.13 Million
412,900 Added 31.49%
1,723,908 $9.5 Million
Q3 2021

Nov 15, 2021

BUY
$5.18 - $7.41 $586,376 - $838,812
113,200 Added 9.45%
1,311,008 $9.45 Million
Q2 2021

Aug 16, 2021

BUY
$3.94 - $6.75 $1.16 Million - $1.99 Million
295,500 Added 32.75%
1,197,808 $7.91 Million
Q1 2021

May 17, 2021

BUY
$4.03 - $7.25 $2.87 Million - $5.16 Million
711,400 Added 372.64%
902,308 $3.93 Million
Q4 2020

Feb 16, 2021

BUY
$2.78 - $4.5 $530,724 - $859,086
190,908 New
190,908 $729,000
Q2 2020

Aug 14, 2020

SELL
$1.66 - $2.73 $37,179 - $61,143
-22,397 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$1.35 - $4.05 $30,235 - $90,707
22,397 New
22,397 $56,000
Q4 2019

Feb 14, 2020

SELL
$2.3 - $4.6 $31,298 - $62,596
-13,608 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$2.9 - $9.56 $39,463 - $130,092
13,608 New
13,608 $39,000

Others Institutions Holding VRAY

About ViewRay, Inc.


  • Ticker VRAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 181,010,000
  • Market Cap $1.81M
  • Description
  • ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin tox...
More about VRAY
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.